Free Trial
→ Claim Your FREE Protection Guide (From American Alternative) (Ad)

Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 45

Hess stock to see 96% growth in EPS
January 29, 2024 4:45 AM ET

Hess stock to see 96% growth in EPS

Gabriel Osorio-Mazilli

Hess stock could be the biggest winner in the United Staes oil industry, the macro certainly supports it, analysts and markets are all over it too

NYSE:OXYNYSE:HESNYSEARCA:XLE
Read Hess stock to see 96% growth in EPS
3 well-known consumer cyclical stocks offering 5% dividends
January 26, 2024 6:10 AM ET

3 well-known consumer cyclical stocks offering 5% dividends

MarketBeat Staff

If the domestic economy strengthens, consumer cyclicals offering dividends - like these three large caps - may generate a blend of growth and income in 2024.

NYSE:FNASDAQ:HASNASDAQ:WEN
Read 3 well-known consumer cyclical stocks offering 5% dividends
3 large caps near 52-week lows with large dividends
January 26, 2024 5:47 AM ET

3 large caps near 52-week lows with large dividends

MarketBeat Staff

For value investors that like to buy low and bank big dividend yields, these 3 underperforming large caps are worth a look.

NYSE:DVNNYSE:ESNYSE:UL
Read 3 large caps near 52-week lows with large dividends
Intuitive Surgical's leap forward is a surgical revolution
January 25, 2024 11:02 AM ET

Intuitive Surgical's leap forward is a surgical revolution

Jeffrey Neal Johnson

Intuitive Surgical, Inc. reported strong growth in 2023 and anticipates further expansion in 2024 with the launch of the da Vinci 5.

NASDAQ:ISRG
Read Intuitive Surgical's leap forward is a surgical revolution
Abbott Laboratories on track for new highs in 2024 
January 25, 2024 8:04 AM ET

Abbott Laboratories on track for new highs in 2024 

Thomas Hughes

Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact.

NYSE:RJFNYSE:JPMNASDAQ:ISRG
Read Abbott Laboratories on track for new highs in 2024 
Super Micro Computer hits record high ahead of its earnings
January 25, 2024 7:35 AM ET

Super Micro Computer hits record high ahead of its earnings

Ryan Hasson

SMCI recently broke out of a multi-month consolidation, surpassing $350 resistance, taking its one-year performance to a remarkable 486% increase.

NASDAQ:SMCI
Read Super Micro Computer hits record high ahead of its earnings
The EV bubble burst: Tesla looks to the future but wait to buy in
January 25, 2024 7:22 AM ET

The EV bubble burst: Tesla looks to the future but wait to buy in

Thomas Hughes

Tesla struggled in Q4 as price cuts dug into the top and bottom lines. Demand for EVs is slacking off, and 2024 will be slow for the industry.

NASDAQ:ENVXNYSE:AMPXNASDAQ:PLUG
Read The EV bubble burst: Tesla looks to the future but wait to buy in
When does 3M’s stumble become a buy?
January 25, 2024 7:00 AM ET

When does 3M’s stumble become a buy?

Sam Quirke

For those of us watching on from the sidelines, is there a buying opportunity still to be found here? Let's dive in and take a look.

NYSE:MMM
Read When does 3M’s stumble become a buy?
How to use the Greeks for your options trading
January 25, 2024 6:18 AM ET

How to use the Greeks for your options trading

Jea Yu

Whether you’re new to or are experienced with stock options trading, you’ll always be exposed to the Greeks on any stock that has options

NASDAQ:AMD
Read How to use the Greeks for your options trading
Flutter Entertainment flies to $100 ahead of NYSE listing
January 25, 2024 6:05 AM ET

Flutter Entertainment flies to $100 ahead of NYSE listing

MarketBeat Staff

The market reacted favorably to Flutter's Q4 financial results as the stock gets ready to begin trading on the NYSE next week.

OTCMKTS:PDYPYNASDAQ:DKNG
Read Flutter Entertainment flies to $100 ahead of NYSE listing
These 5 growth stocks are now in buy ranges
January 25, 2024 6:00 AM ET

These 5 growth stocks are now in buy ranges

Kate Stalter

Affirm, MongoDB, UIPath, Synopsys and Crispr's charts signal buy opportunities as these top-performing tech and biotech stocks consolidate below prior highs.

NASDAQ:ANSSNASDAQ:SNPSNYSEARCA:XLK
Read These 5 growth stocks are now in buy ranges
Intuitive Surgical’s post-earnings dip is a healthy time to buy
January 25, 2024 5:10 AM ET

Intuitive Surgical’s post-earnings dip is a healthy time to buy

Thomas Hughes

Intuitive Surgical had a solid quarter, but strength was expected, and the stock sold off; a healthy correction is good, but will investors buy the dip?

NYSE:JNJNASDAQ:ISRG
Read Intuitive Surgical’s post-earnings dip is a healthy time to buy
Is Xerox’s 6% dividend a value deal or a value trap?
January 24, 2024 5:43 AM ET

Is Xerox’s 6% dividend a value deal or a value trap?

Gabriel Osorio-Mazilli

Xerox stock is attracting a new wave of investors with its 6.0% dividend yield, particularly realizing the new turnaround that could come soon.

NYSE:BACNYSE:WFCNYSE:C
Read Is Xerox’s 6% dividend a value deal or a value trap?
Buy any dip in GE stock even with uncertainty around the spinoff
January 24, 2024 5:24 AM ET

Buy any dip in GE stock even with uncertainty around the spinoff

Chris Markoch

After issuing light guidance for Q1, investors should consider buying any dip in GE stock ahead of the spin-off of its Vernova power-generation business

NYSE:GE
Read Buy any dip in GE stock even with uncertainty around the spinoff
Why Microsoft won’t stop at $400
January 24, 2024 5:08 AM ET

Why Microsoft won’t stop at $400

Sam Quirke

It would take a lot for next week's results to be anything but surprisingly good or for management’s forward guidance to be anything short of stellar. 

NASDAQ:AAPLNASDAQ:MSFT
Read Why Microsoft won’t stop at $400
Johnson and Johnson: Q4, courtrooms and cutting-edge science
January 23, 2024 11:34 AM ET

Johnson and Johnson: Q4, courtrooms and cutting-edge science

Jeffrey Neal Johnson

Johnson & Johnson excels in advancing medical innovation while adeptly handling market and legal challenges.

NYSE:JNJ
Read Johnson and Johnson: Q4, courtrooms and cutting-edge science
3 reasons to buy Meta stock ahead of earnings
January 23, 2024 7:49 AM ET

3 reasons to buy Meta stock ahead of earnings

Sam Quirke

Yesterday saw them set a fresh all-time high, topping 2021’s effort, so it’s clear expectations are high from the street for a knockout report. 

NASDAQ:META
Read 3 reasons to buy Meta stock ahead of earnings
Procter & Gamble: a trend-following signal for income investors
January 23, 2024 7:45 AM ET

Procter & Gamble: a trend-following signal for income investors

Thomas Hughes

Proctor & Gamble had a solid quarter with ample FCF to support the capital return outlook; analysts view this stock as undervalued.

NYSE:PG
Read Procter & Gamble: a trend-following signal for income investors
Johnson & Johnson's stock price is at a critical turning point
January 23, 2024 6:12 AM ET

Johnson & Johnson's stock price is at a critical turning point

Thomas Hughes

Johnson & Johnson's dividend is safe for 2024 and may include another increase for this Dividend King. Results suggest another solid quarter for medtech.

NYSE:ABTNYSE:JNJ
Read Johnson & Johnson's stock price is at a critical turning point
3 personal care stocks that smell like good earnings plays
January 23, 2024 5:59 AM ET

3 personal care stocks that smell like good earnings plays

MarketBeat Staff

Management remarks about how they plan to use technology to drive growth could matter just as much as near-term financials for these personal care companies.

NYSE:ELFNASDAQ:IPARNYSE:KVUE
Read 3 personal care stocks that smell like good earnings plays
Why the market is overpaying for Netflix stock ahead of earnings
January 23, 2024 5:35 AM ET

Why the market is overpaying for Netflix stock ahead of earnings

Gabriel Osorio-Mazilli

Netflix stock could prove the market just why it's worth it to overpay for a stock ahead of a bullish earnings expectation. Management lays the path for a rally

NASDAQ:WBDNASDAQ:NFLXNYSE:DIS
Read Why the market is overpaying for Netflix stock ahead of earnings
Ceragon is the under-the-radar networking stock you should know
January 23, 2024 5:30 AM ET

Ceragon is the under-the-radar networking stock you should know

Jea Yu

Ceragon Networks Ltd. (NASDAQ: CRNT) is a provider of high-performance wireless infrastructure solutions to cellular operators and wireless service providers.

NASDAQ:CRNTNYSE:NOKNASDAQ:CSCO
Read Ceragon is the under-the-radar networking stock you should know
3 top rated Chinese stocks in prime value territory
January 23, 2024 5:06 AM ET

3 top rated Chinese stocks in prime value territory

Ryan Hasson

With substantial recent declines, Alibaba, Baidu, and NetEase may be entering oversold value territory, presenting potential opportunities for a turnaround.

NYSE:BABANASDAQ:NTESNASDAQ:BIDU
Read 3 top rated Chinese stocks in prime value territory
Vita Coco: Stirring the market with strategic shifts
January 22, 2024 1:46 PM ET

Vita Coco: Stirring the market with strategic shifts

Jeffrey Neal Johnson

Vita Coco thrives in the health and wellness beverage industry despite market challenges and internal shifts, showcasing its strategic growth and adaptability.

NASDAQ:COCONYSE:DEONASDAQ:COKE
Read Vita Coco: Stirring the market with strategic shifts
Page 45 of 65